Nvidia's massive share repurchase authorization indicates that the stock is undervalued.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the launch of its inaugural Emerging Leadership & Innovation in Cell Therapy Excellence ...

Joby Aviation sits within striking distance of its 52-week low while commercial passenger flights loom on the horizon, and ...

This under-the-radar consumer discretionary stock boasts a Superscore of 73 from the Hidden Gems Primary database, part of ...

Learn more Meta Platforms' (NASDAQ: META) stock has emerged from its slumber, but I think the best days are still ahead of it ...

Alphabet shares rose 2.3% after Google unveiled Gemini 4 Argon, its new flagship AI model aimed at challenging OpenAI and ...

IBM has rolled out a self-hosting mode of deployment for IBM Bob, which is an agent-based AI system used for software ...

Wall Street is questioning Nvidia’s $500B AI financing plan as lenders debate whether GPUs can support long-term ...

NVDA is trading at $231.24, pressing the upper Bollinger Band with momentum firmly intact and a historic $235 billion buyback ...

Explore the latest developments in Cosa Resources Corp. stock, including a recent drilling program announcement and its ...

Kalshi terminates its Volume Incentive Program as the CFTC examines over $5 billion in Ether futures trades. Platform eyes ...

Kalshi terminates its volume rewards program as CFTC examines over $5 billion in Ether futures trades. The platform eyes $1B raise at $40B valuation.